Abbott Laboratories (Pakistan) Ltd. Cash flow Statement
Figures in Million
Consolidated Cash Flow Results
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
No of Months
12
12
12
12
12
12
Profit Before Tax
9,021.00
2,041.00
6,147.00
8,410.00
6,243.00
2,510.00
Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Changes In working Capital
-3,645.00
-1,453.00
-1,238.00
-313.00
2,378.00
-1,855.00
Cash Flow after changes in Working Capital
0.00
0.00
0.00
0.00
0.00
0.00
Cash Flow from Operating Activities
5,134.00
665.00
4,693.00
8,325.00
8,439.00
58.00
Cash Flow from Investing Activities
-2,840.00
-2,934.00
-1,402.00
-3,972.00
-1,301.00
-1,850.00
Cash Flow from Financing Activities
-1,148.00
-1,485.00
-1,118.00
-5,222.00
-2,406.00
-1,129.00
Net Cash Inflow / Outflow
1,145.00
-3,755.00
2,172.00
-869.00
4,731.00
-2,920.00
Opening Cash & Cash Equivalents
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
0.00
0.00
0.00
0.00
0.00
0.00
Closing Cash & Cash Equivalent
0.00
0.00
0.00
0.00
0.00
0.00
Figures in PKR Million
Seasonal companies are compared with the same quarter last year
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of Abbott Laboratories (Pakistan) Ltd.
Figures in Million
consolidated Cash Flow Results
Change(PKR)
Change(%)
Profit Before Tax
9021.989
10475.696
-1,454.00
-13.88%
Adjustment
0
0
0.00
0.00%
Changes In working Capital
-3645.427
-4340.409
695.00
16.01%
Cash Flow after changes in Working Capital
0
0
0.00
0.00%
Cash Flow from Operating Activities
5134.365
5596.547
-462.00
-8.26%
Cash Flow from Investing Activities
-2840.535
-2640.979
-200.00
-7.56%
Cash Flow from Financing Activities
-1148.193
-52.878
-1,096.00
-2071.40%
Net Cash Inflow / Outflow
1145.637
2902.69
-1,757.00
-60.53%
Opening Cash & Cash Equivalents
0
0
0.00
0.00%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
0
0
0.00
0.00%
Closing Cash & Cash Equivalent
0
0
0.00
0.00%
Cash Flow - Snapshot (Consolidated) - Dec'24
YoY Growth in year ended Dec 2024 is 671.84% vs -85.83% in Dec 2023
Dec'24
Dec'23
Change(%)
Cash Flow from Operating Activities
5,134.36
665.21
671.84%






